{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:07:48Z","timestamp":1774260468805,"version":"3.50.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["12182"],"award-info":[{"award-number":["12182"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["18718"],"award-info":[{"award-number":["18718"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R35CA197706"],"award-info":[{"award-number":["R35CA197706"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["R01CA190740"],"award-info":[{"award-number":["R01CA190740"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pancreatic and peri-pancreatic neoplasms encompass a variety of histotypes characterized by a heterogeneous prognostic impact. miRNAs are considered efficient candidate biomarkers due to their high stability in tissues and body fluids. We applied Nanostring profiling of circulating exosomal miRNAs to distinct pancreatic lesions in order to establish a source for biomarker development.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A series of 140 plasma samples obtained from patients affected by pancreatic ductal adenocarcinoma (PDAC, <jats:italic>n<\/jats:italic>\u2009=\u200958), pancreatic neuroendocrine tumors (PanNET, <jats:italic>n<\/jats:italic>\u2009=\u200942), intraductal papillary mucinous neoplasms (IPMN, <jats:italic>n<\/jats:italic>\u2009=\u200920), and ampulla of Vater carcinomas (AVC, <jats:italic>n<\/jats:italic>\u2009=\u200920) were analyzed. Comprehensive miRNA profiling was performed on plasma-derived exosomes. Relevant miRNAs were validated by qRT-PCR and in situ hybridization (ISH).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Lesion specific miRNAs were identified through multiple disease comparisons. Selected miRNAs were validated in the plasma by qRT-PCR and at tissue level by ISH. We leveraged the presence of clinical subtypes with each disease cohort to identify miRNAs that are differentially enriched in aggressive phenotypes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study shows that pancreatic lesions are characterized by specific exosomal-miRNA signatures. We also provide the basis for further explorations in order to better understand the relevance of these signatures in pancreatic neoplasms.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-020-01287-y","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T12:04:25Z","timestamp":1588766665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Exosomal miRNA signatures of pancreatic lesions"],"prefix":"10.1186","volume":"20","author":[{"given":"Caterina","family":"Vicentini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Calore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Nigita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Fadda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Simbolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Sperandio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Luchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita T.","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Maria","family":"Croce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Corbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6515-5482","authenticated-orcid":false,"given":"Matteo","family":"Fassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,6]]},"reference":[{"issue":"1","key":"1287_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1287_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/ijc.30670","volume":"141","author":"B Zhou","year":"2017","unstructured":"Zhou B, Xu JW, Cheng YG, Gao JY, Hu SY, Wang L, et al. Early detection of pancreatic cancer: where are we now and where are we going? Int J Cancer. 2017;141(2):231.","journal-title":"Int J Cancer"},{"issue":"10039","key":"1287_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","volume":"388","author":"T Kamisawa","year":"2016","unstructured":"Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016;388(10039):73.","journal-title":"Lancet."},{"issue":"5","key":"1287_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3322\/caac.21190","volume":"63","author":"CL Wolfgang","year":"2013","unstructured":"Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, et al. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013;63(5):318.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1287_CR5","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.bpg.2013.01.003","volume":"26","author":"P Capelli","year":"2012","unstructured":"Capelli P, Fassan M, Scarpa A. Pathology - grading and staging of GEP-NETs. Best Pract Res Clin Gastroenterol. 2012;26(6):705.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"1287_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","volume":"32","author":"Cancer Genome Atlas Research Network","year":"2017","unstructured":"Cancer Genome Atlas Research Network. Electronic address aadhe, Cancer Genome Atlas Research N. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2017;32(2):185.","journal-title":"Cancer Cell"},{"issue":"7643","key":"1287_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature21063","volume":"543","author":"A Scarpa","year":"2017","unstructured":"Scarpa A, Chang DK, Nones K, Corbo V, Patch AM, Bailey P, et al. Whole-genome landscape of pancreatic neuroendocrine tumours. Nature. 2017;543(7643):65.","journal-title":"Nature."},{"issue":"32","key":"1287_CR8","doi-asserted-by":"publisher","first-page":"11182","DOI":"10.3748\/wjg.v20.i32.11182","volume":"20","author":"AE Becker","year":"2014","unstructured":"Becker AE, Hernandez YG, Frucht H, Lucas AL. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. World J Gastroenterol. 2014;20(32):11182.","journal-title":"World J Gastroenterol"},{"key":"1287_CR9","doi-asserted-by":"crossref","unstructured":"Pham A, Forsmark C. Chronic pancreatitis: review and update of etiology, risk factors, and management. F1000Res. 2018;7.","DOI":"10.12688\/f1000research.12852.1"},{"issue":"11","key":"1287_CR10","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/s41395-018-0255-9","volume":"113","author":"O Sadr-Azodi","year":"2018","unstructured":"Sadr-Azodi O, Oskarsson V, Discacciati A, Videhult P, Askling J, Ekbom A. Pancreatic Cancer following acute pancreatitis: a population-based matched cohort study. Am J Gastroenterol. 2018;113(11):1711.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"1287_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4251\/wjgo.v10.i10.317","volume":"10","author":"G Riva","year":"2018","unstructured":"Riva G, Pea A, Pilati C, Fiadone G, Lawlor RT, Scarpa A, et al. Histo-molecular oncogenesis of pancreatic cancer: from precancerous lesions to invasive ductal adenocarcinoma. World J Gastrointest Oncol. 2018;10(10):317.","journal-title":"World J Gastrointest Oncol."},{"issue":"3","key":"1287_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/path.4344","volume":"233","author":"E Amato","year":"2014","unstructured":"Amato E, Molin MD, Mafficini A, Yu J, Malleo G, Rusev B, et al. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. J Pathol. 2014;233(3):217.","journal-title":"J Pathol"},{"issue":"1","key":"1287_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/path.4884","volume":"242","author":"W Hosoda","year":"2017","unstructured":"Hosoda W, Chianchiano P, Griffin JF, Pittman ME, Brosens LA, Noe M, et al. Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia (HG-PanIN) reveal paucity of alterations in TP53 and SMAD4. J Pathol. 2017;242(1):16.","journal-title":"J Pathol"},{"issue":"9","key":"1287_CR14","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1136\/gutjnl-2017-315062","volume":"67","author":"M Felsenstein","year":"2018","unstructured":"Felsenstein M, Noe M, Masica DL, Hosoda W, Chianchiano P, Fischer CG, et al. IPMNs with co-occurring invasive cancers: neighbours but not always relatives. Gut. 2018;67(9):1652.","journal-title":"Gut."},{"issue":"11","key":"1287_CR15","doi-asserted-by":"publisher","first-page":"370","DOI":"10.4251\/wjgo.v10.i11.370","volume":"10","author":"A Pea","year":"2018","unstructured":"Pea A, Riva G, Bernasconi R, Sereni E, Lawlor RT, Scarpa A, et al. Ampulla of Vater carcinoma: molecular landscape and clinical implications. World J Gastrointest Oncol. 2018;10(11):370.","journal-title":"World J Gastrointest Oncol."},{"issue":"1","key":"1287_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/hpb.12078","volume":"16","author":"J He","year":"2014","unstructured":"He J, Ahuja N, Makary MA, Cameron JL, Eckhauser FE, Choti MA, et al. 2564 resected periampullary adenocarcinomas at a single institution: trends over three decades. HPB (Oxford). 2014;16(1):83.","journal-title":"HPB (Oxford)"},{"issue":"7","key":"1287_CR17","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/jso.21374","volume":"100","author":"J Albores-Saavedra","year":"2009","unstructured":"Albores-Saavedra J, Schwartz AM, Batich K, Henson DE. Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program. J Surg Oncol. 2009;100(7):598.","journal-title":"J Surg Oncol"},{"issue":"1","key":"1287_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/SLA.0000000000001999","volume":"267","author":"A Mafficini","year":"2018","unstructured":"Mafficini A, Amato E, Cataldo I, Rusev BC, Bertoncello L, Corbo V, et al. Ampulla of Vater carcinoma: sequencing analysis identifies TP53 status as a novel independent prognostic factor and potentially actionable ERBB, PI3K, and WNT pathways gene mutations. Ann Surg. 2018;267(1):149.","journal-title":"Ann Surg"},{"issue":"3","key":"1287_CR19","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1148\/rg.343125191","volume":"34","author":"P Nikolaidis","year":"2014","unstructured":"Nikolaidis P, Hammond NA, Day K, Yaghmai V, Wood CG 3rd, Mosbach DS, et al. Imaging features of benign and malignant ampullary and periampullary lesions. Radiographics. 2014;34(3):624.","journal-title":"Radiographics."},{"key":"1287_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","volume":"9","author":"G Di Leva","year":"2014","unstructured":"Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol. 2014;9:287.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"1287_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.gde.2013.01.004","volume":"23","author":"G Di Leva","year":"2013","unstructured":"Di Leva G, Croce CM. miRNA profiling of cancer. Curr Opin Genet Dev. 2013;23(1):3.","journal-title":"Curr Opin Genet Dev."},{"issue":"16","key":"1287_CR22","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.4161\/cc.7.16.6453","volume":"7","author":"PP Medina","year":"2008","unstructured":"Medina PP, Slack FJ. microRNAs and cancer: an overview. Cell Cycle. 2008;7(16):2485.","journal-title":"Cell Cycle"},{"issue":"10","key":"1287_CR23","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1261\/rna.642907","volume":"13","author":"Y Xi","year":"2007","unstructured":"Xi Y, Nakajima G, Gavin E, Morris CG, Kudo K, Hayashi K, et al. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA. 2007;13(10):1668.","journal-title":"RNA."},{"issue":"30","key":"1287_CR24","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30):10513.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"1287_CR25","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.tibs.2016.08.004","volume":"41","author":"A Turchinovich","year":"2016","unstructured":"Turchinovich A, Tonevitsky AG, Burwinkel B. Extracellular miRNA: a collision of two paradigms. Trends Biochem Sci. 2016;41(10):883.","journal-title":"Trends Biochem Sci"},{"issue":"21","key":"1287_CR26","doi-asserted-by":"publisher","first-page":"8259","DOI":"10.1158\/0008-5472.CAN-10-0604","volume":"70","author":"M Katakowski","year":"2010","unstructured":"Katakowski M, Buller B, Wang X, Rogers T, Chopp M. Functional microRNA is transferred between glioma cells. Cancer Res. 2010;70(21):8259.","journal-title":"Cancer Res"},{"issue":"12","key":"1287_CR27","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.4049\/jimmunol.1301728","volume":"191","author":"A Aucher","year":"2013","unstructured":"Aucher A, Rudnicka D, Davis DM. MicroRNAs transfer from human macrophages to hepato-carcinoma cells and inhibit proliferation. J Immunol. 2013;191(12):6250.","journal-title":"J Immunol"},{"issue":"4","key":"1287_CR28","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s00268-008-9833-0","volume":"33","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Li M, Wang H, Fisher WE, Lin PH, Yao Q, et al. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg. 2009;33(4):698.","journal-title":"World J Surg"},{"issue":"4","key":"1287_CR29","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1158\/1078-0432.CCR-11-2347","volume":"18","author":"J Yu","year":"2012","unstructured":"Yu J, Li A, Hong SM, Hruban RH, Goggins M. MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin Cancer Res. 2012;18(4):981.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"1287_CR30","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1158\/1940-6207.CAPR-15-0094","volume":"8","author":"J Permuth-Wey","year":"2015","unstructured":"Permuth-Wey J, Chen DT, Fulp WJ, Yoder SJ, Zhang Y, Georgeades C, et al. Plasma MicroRNAs as novel biomarkers for patients with Intraductal papillary mucinous neoplasms of the pancreas. Cancer Prev Res (Phila). 2015;8(9):826.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"5","key":"1287_CR31","first-page":"2249","volume":"34","author":"C Thorns","year":"2014","unstructured":"Thorns C, Schurmann C, Gebauer N, Wallaschofski H, Kumpers C, Bernard V, et al. Global microRNA profiling of pancreatic neuroendocrine neoplasias. Anticancer Res. 2014;34(5):2249.","journal-title":"Anticancer Res"},{"issue":"4","key":"1287_CR32","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.molonc.2014.12.002","volume":"9","author":"V Sandhu","year":"2015","unstructured":"Sandhu V, Bowitz Lothe IM, Labori KJ, Lingjaerde OC, Buanes T, Dalsgaard AM, et al. Molecular signatures of mRNAs and miRNAs as prognostic biomarkers in pancreatobiliary and intestinal types of periampullary adenocarcinomas. Mol Oncol. 2015;9(4):758.","journal-title":"Mol Oncol"},{"issue":"14","key":"1287_CR33","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1158\/0008-5472.CAN-16-2984","volume":"77","author":"L Casadei","year":"2017","unstructured":"Casadei L, Calore F, Creighton CJ, Guescini M, Batte K, Iwenofu OH, et al. Exosome-derived miR-25-3p and miR-92a-3p stimulate Liposarcoma progression. Cancer Res. 2017;77(14):3846.","journal-title":"Cancer Res"},{"key":"1287_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ebiom.2018.03.022","volume":"30","author":"A Drusco","year":"2018","unstructured":"Drusco A, Fadda P, Nigita G, Fassan M, Bottoni A, Gardiman MP, et al. Circulating Micrornas Predict Survival of Patients with Tumors of Glial Origin. EBioMedicine. 2018;30:105.","journal-title":"EBioMedicine."},{"key":"1287_CR35","doi-asserted-by":"crossref","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Series B. 1995;57:289-300.","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"issue":"7","key":"1287_CR36","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1136\/gutjnl-2016-312278","volume":"66","author":"P Carotenuto","year":"2017","unstructured":"Carotenuto P, Fassan M, Pandolfo R, Lampis A, Vicentini C, Cascione L, et al. Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers. Gut. 2017;66(7):1268.","journal-title":"Gut."},{"issue":"5","key":"1287_CR37","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3322\/caac.21244","volume":"64","author":"I Berindan-Neagoe","year":"2014","unstructured":"Berindan-Neagoe I, Monroig Pdel C, Pasculli B, Calin GA. MicroRNAome genome: a treasure for cancer diagnosis and therapy. CA Cancer J Clin. 2014;64(5):311.","journal-title":"CA Cancer J Clin"},{"issue":"27","key":"1287_CR38","doi-asserted-by":"publisher","first-page":"8284","DOI":"10.3748\/wjg.v21.i27.8284","volume":"21","author":"M Hollis","year":"2015","unstructured":"Hollis M, Nair K, Vyas A, Chaturvedi LS, Gambhir S, Vyas D. MicroRNAs potential utility in colon cancer: early detection, prognosis, and chemosensitivity. World J Gastroenterol. 2015;21(27):8284.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1287_CR39","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1158\/1078-0432.CCR-11-0679","volume":"18","author":"NB Jamieson","year":"2012","unstructured":"Jamieson NB, Morran DC, Morton JP, Ali A, Dickson EJ, Carter CR, et al. MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Clin Cancer Res. 2012;18(2):534.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"1287_CR40","doi-asserted-by":"publisher","first-page":"4528","DOI":"10.1158\/0008-5472.CAN-09-4467","volume":"70","author":"E Giovannetti","year":"2010","unstructured":"Giovannetti E, Funel N, Peters GJ, Del Chiaro M, Erozenci LA, Vasile E, et al. MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res. 2010;70(11):4528.","journal-title":"Cancer Res"},{"issue":"1","key":"1287_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/MPA.0b013e3182592ba7","volume":"42","author":"IG Papaconstantinou","year":"2013","unstructured":"Papaconstantinou IG, Manta A, Gazouli M, Lyberopoulou A, Lykoudis PM, Polymeneas G, et al. Expression of microRNAs in patients with pancreatic cancer and its prognostic significance. Pancreas. 2013;42(1):67.","journal-title":"Pancreas."},{"issue":"11","key":"1287_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049145","volume":"7","author":"E Giovannetti","year":"2012","unstructured":"Giovannetti E, van der Velde A, Funel N, Vasile E, Perrone V, Leon LG, et al. High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancer. PLoS One. 2012;7(11):e49145.","journal-title":"PLoS One"},{"issue":"6","key":"1287_CR43","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1097\/SLA.0000000000001809","volume":"265","author":"E Vila-Navarro","year":"2017","unstructured":"Vila-Navarro E, Vila-Casadesus M, Moreira L, Duran-Sanchon S, Sinha R, Gines A, et al. MicroRNAs for detection of pancreatic Neoplasia: biomarker discovery by next-generation sequencing and validation in 2 independent cohorts. Ann Surg. 2017;265(6):1226.","journal-title":"Ann Surg"},{"issue":"4","key":"1287_CR44","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/jama.2013.284664","volume":"311","author":"NA Schultz","year":"2014","unstructured":"Schultz NA, Dehlendorff C, Jensen BV, Bjerregaard JK, Nielsen KR, Bojesen SE, et al. MicroRNA biomarkers in whole blood for detection of pancreatic cancer. JAMA. 2014;311(4):392.","journal-title":"JAMA."},{"issue":"1","key":"1287_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4251\/wjgo.v6.i1.22","volume":"6","author":"GA Ganepola","year":"2014","unstructured":"Ganepola GA, Rutledge JR, Suman P, Yiengpruksawan A, Chang DH. Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer. World J Gastrointest Oncol. 2014;6(1):22.","journal-title":"World J Gastrointest Oncol"},{"issue":"8","key":"1287_CR46","doi-asserted-by":"publisher","first-page":"696","DOI":"10.7150\/jca.10094","volume":"5","author":"J Wang","year":"2014","unstructured":"Wang J, Raimondo M, Guha S, Chen J, Diao L, Dong X, et al. Circulating microRNAs in pancreatic juice as candidate biomarkers of pancreatic Cancer. J Cancer. 2014;5(8):696.","journal-title":"J Cancer"},{"issue":"3","key":"1287_CR47","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1373\/clinchem.2011.172767","volume":"58","author":"R Liu","year":"2012","unstructured":"Liu R, Chen X, Du Y, Yao W, Shen L, Wang C, et al. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem. 2012;58(3):610.","journal-title":"Clin Chem"},{"issue":"2","key":"1287_CR48","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s10620-010-1285-3","volume":"56","author":"X Kong","year":"2011","unstructured":"Kong X, Du Y, Wang G, Gao J, Gong Y, Li L, et al. Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. Dig Dis Sci. 2011;56(2):602.","journal-title":"Dig Dis Sci"},{"issue":"28","key":"1287_CR49","doi-asserted-by":"publisher","first-page":"8527","DOI":"10.3748\/wjg.v21.i28.8527","volume":"21","author":"T Kishikawa","year":"2015","unstructured":"Kishikawa T, Otsuka M, Ohno M, Yoshikawa T, Takata A, Koike K. Circulating RNAs as new biomarkers for detecting pancreatic cancer. World J Gastroenterol. 2015;21(28):8527.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"1287_CR50","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/modpathol.2009.161","volume":"23","author":"K Ruebel","year":"2010","unstructured":"Ruebel K, Leontovich AA, Stilling GA, Zhang S, Righi A, Jin L, et al. MicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progression. Mod Pathol. 2010;23(3):367.","journal-title":"Mod Pathol"},{"issue":"29","key":"1287_CR51","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1200\/JCO.2005.05.5194","volume":"24","author":"C Roldo","year":"2006","unstructured":"Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol. 2006;24(29):4677.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1287_CR52","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/modpathol.2012.216","volume":"26","author":"SC Li","year":"2013","unstructured":"Li SC, Essaghir A, Martijn C, Lloyd RV, Demoulin JB, Oberg K, et al. Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors. Mod Pathol. 2013;26(5):685.","journal-title":"Mod Pathol"},{"issue":"1","key":"1287_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116869","volume":"10","author":"J Permuth-Wey","year":"2015","unstructured":"Permuth-Wey J, Chen YA, Fisher K, McCarthy S, Qu X, Lloyd MC, et al. A genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreas. PLoS One. 2015;10(1):e0116869.","journal-title":"PLoS One"},{"issue":"5","key":"1287_CR54","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.surg.2012.11.016","volume":"153","author":"N Lubezky","year":"2013","unstructured":"Lubezky N, Loewenstein S, Ben-Haim M, Brazowski E, Marmor S, Pasmanik-Chor M, et al. MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas. Surgery. 2013;153(5):663.","journal-title":"Surgery."},{"issue":"3","key":"1287_CR55","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/annonc\/mds513","volume":"24","author":"S Caponi","year":"2013","unstructured":"Caponi S, Funel N, Frampton AE, Mosca F, Santarpia L, Van der Velde AG, et al. The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms. Ann Oncol. 2013;24(3):734.","journal-title":"Ann Oncol"},{"issue":"3","key":"1287_CR56","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrgastro.2011.2","volume":"8","author":"H Matthaei","year":"2011","unstructured":"Matthaei H, Schulick RD, Hruban RH, Maitra A. Cystic precursors to invasive pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2011;8(3):141.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"1287_CR57","doi-asserted-by":"publisher","first-page":"101042831769501","DOI":"10.1177\/1010428317695018","volume":"39","author":"K Murali Manohar","year":"2017","unstructured":"Murali Manohar K, Sasikala M, Kvsrr Y, Sunil V, Talukdar R, Murthy H, et al. Plasma microRNA192 in combination with serum CA19-9 as non-invasive prognostic biomarker in periampullary carcinoma. Tumour Biol. 2017;39(3):1010428317695018.","journal-title":"Tumour Biol"},{"issue":"24","key":"1287_CR58","doi-asserted-by":"publisher","first-page":"7864","DOI":"10.3748\/wjg.v20.i24.7864","volume":"20","author":"ES Lee","year":"2014","unstructured":"Lee ES, Lee JM. Imaging diagnosis of pancreatic cancer: a state-of-the-art review. World J Gastroenterol. 2014;20(24):7864.","journal-title":"World J Gastroenterol"},{"key":"1287_CR59","doi-asserted-by":"crossref","unstructured":"Cheng L, Sharples RA, Scicluna BJ, Hill AF. Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles. 2014;3.","DOI":"10.3402\/jev.v3.23743"},{"issue":"2","key":"1287_CR60","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.3390\/molecules19021568","volume":"19","author":"Q Ge","year":"2014","unstructured":"Ge Q, Zhou Y, Lu J, Bai Y, Xie X, Lu Z. miRNA in plasma exosome is stable under different storage conditions. Molecules. 2014;19(2):1568.","journal-title":"Molecules."},{"issue":"1","key":"1287_CR61","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1038\/s41598-018-21113-6","volume":"8","author":"J Zheng","year":"2018","unstructured":"Zheng J, Yu L, Chen W, Lu X, Fan X. Circulating exosomal microRNAs reveal the mechanism of Fructus Meliae Toosendan-induced liver injury in mice. Sci Rep. 2018;8(1):2832.","journal-title":"Sci Rep"},{"issue":"4","key":"1287_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092921","volume":"9","author":"H Ogata-Kawata","year":"2014","unstructured":"Ogata-Kawata H, Izumiya M, Kurioka D, Honma Y, Yamada Y, Furuta K, et al. Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014;9(4):e92921.","journal-title":"PLoS One"},{"issue":"1","key":"1287_CR63","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ygyno.2008.04.033","volume":"110","author":"DD Taylor","year":"2008","unstructured":"Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008;110(1):13.","journal-title":"Gynecol Oncol"},{"issue":"9329","key":"1287_CR64","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0140-6736(02)09552-1","volume":"360","author":"F Andre","year":"2002","unstructured":"Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet. 2002;360(9329):295.","journal-title":"Lancet."},{"key":"1287_CR65","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13148-017-0355-1","volume":"9","author":"DA Armstrong","year":"2017","unstructured":"Armstrong DA, Nymon AB, Ringelberg CS, Lesseur C, Hazlett HF, Howard L, et al. Pulmonary microRNA profiling: implications in upper lobe predominant lung disease. Clin Epigenetics. 2017;9:56.","journal-title":"Clin Epigenetics"},{"issue":"12","key":"1287_CR66","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.86820","volume":"1","author":"A Nakamura","year":"2016","unstructured":"Nakamura A, Rampersaud YR, Sharma A, Lewis SJ, Wu B, Datta P, et al. Identification of microRNA-181a-5p and microRNA-4454 as mediators of facet cartilage degeneration. JCI Insight. 2016;1(12):e86820.","journal-title":"JCI Insight"},{"issue":"6","key":"1287_CR67","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","volume":"17","author":"B Costa-Silva","year":"2015","unstructured":"Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17(6):816.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"1287_CR68","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12079-014-0220-3","volume":"8","author":"A Charrier","year":"2014","unstructured":"Charrier A, Chen R, Chen L, Kemper S, Hattori T, Takigawa M, et al. Connective tissue growth factor (CCN2) and microRNA-21 are components of a positive feedback loop in pancreatic stellate cells (PSC) during chronic pancreatitis and are exported in PSC-derived exosomes. J Cell Commun Signal. 2014;8(2):147.","journal-title":"J Cell Commun Signal"},{"key":"1287_CR69","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1471-2407-8-170","volume":"8","author":"A Westgaard","year":"2008","unstructured":"Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, et al. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma. BMC Cancer. 2008;8:170.","journal-title":"BMC Cancer"},{"issue":"7","key":"1287_CR70","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/00000478-200407000-00005","volume":"28","author":"H Zhou","year":"2004","unstructured":"Zhou H, Schaefer N, Wolff M, Fischer HP. Carcinoma of the ampulla of Vater: comparative histologic\/immunohistochemical classification and follow-up. Am J Surg Pathol. 2004;28(7):875.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1287_CR71","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1097\/01.sla.0000128306.90650.aa","volume":"239","author":"TA Sohn","year":"2004","unstructured":"Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239(6):788.","journal-title":"Ann Surg"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01287-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-020-01287-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01287-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T23:44:09Z","timestamp":1620258249000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-020-01287-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,6]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1287"],"URL":"https:\/\/doi.org\/10.1186\/s12876-020-01287-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,6]]},"assertion":[{"value":"1 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Materials used in the experiments have been collected under the Program 1885 with protocol 52438 approved on November 2010. The protocol includes written informed consent of the patient and were approved by the local ethics committee of the Integrated University Hospital Trust of Verona.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare. The corresponding author of the present manuscript and the co-author Dr. Claudio Luchini are Editorial Board Member of BMC Gastroenterology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}